Vectorite Biomedical Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Mar '26 Mar 6, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Market Capitalization	589	635	935	621	621	492	Upgrade
Market Cap Growth	-3.58%	-32.08%	50.46%	-	26.25%	-21.38%	Upgrade
Enterprise Value	413	442	728	396	375	526	Upgrade
Last Close Price	13.45	14.50	21.35	14.01	14.01	14.01	Upgrade
PE Ratio	-	-	-	-	74.32	-	Upgrade
PS Ratio	8.67	10.99	16.73	14.47	21.59	20.05	Upgrade
PB Ratio	1.50	1.63	2.17	1.41	1.33	1.43	Upgrade
P/TBV Ratio	1.52	1.66	2.29	1.49	1.40	1.56	Upgrade
P/FCF Ratio	-	-	-	44.96	-	-	Upgrade
P/OCF Ratio	-	-	719.97	42.25	-	-	Upgrade
EV/Sales Ratio	6.08	7.65	13.04	9.23	13.03	21.44	Upgrade
EV/FCF Ratio	-40.66	-	-	28.67	-	-	Upgrade
Debt / Equity Ratio	0.00	-	-	-	-	-	Upgrade
Net Debt / Equity Ratio	-0.45	-0.47	-0.47	-0.48	-0.51	-0.26	Upgrade
Net Debt / EBITDA Ratio	18.33	10.74	29.21	9.85	9.23	2.10	Upgrade
Net Debt / FCF Ratio	17.36	12.88	58.92	-15.46	3.54	2.38	Upgrade
Asset Turnover	0.16	0.13	0.12	0.09	0.07	0.07	Upgrade
Inventory Turnover	2.59	3.29	5.31	6.99	4.97	3.72	Upgrade
Quick Ratio	12.20	12.91	16.45	14.10	14.53	6.28	Upgrade
Current Ratio	13.46	14.06	17.53	14.93	15.07	6.74	Upgrade
Return on Equity (ROE)	-5.73%	-9.77%	-1.52%	-5.83%	2.05%	-20.93%	Upgrade
Return on Assets (ROA)	-2.65%	-3.75%	-2.20%	-3.98%	-6.15%	-10.05%	Upgrade
Return on Invested Capital (ROIC)	-8.34%	-12.03%	-7.09%	-13.41%	-17.57%	-24.34%	Upgrade
Return on Capital Employed (ROCE)	-4.50%	-6.50%	-3.70%	-6.80%	-8.90%	-17.20%	Upgrade
Earnings Yield	-3.94%	-6.31%	-0.71%	-4.25%	1.35%	-13.86%	Upgrade
FCF Yield	-1.72%	-2.26%	-0.37%	2.22%	-10.88%	-7.66%	Upgrade
Buyback Yield / Dilution	0.14%	0.14%	-	-1.84%	-47.01%	-14.34%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.